Invesco’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Invesco’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-148,009	Closed	-$2.76M	–	4227
2022 Q1	$2.76M	Buy	148,009 +90,576	+158%	+$1.63M	﹤0.01%	2653
2021 Q4	$1.23M	Sell	57,433 -971,756	-94%	-$19.1M	﹤0.01%	2978
2021 Q3	$19M	Buy	1,029,189 +155,296	+18%	+$3.13M	﹤0.01%	1595
2021 Q2	$18.7M	Buy	873,893 +49,226	+6%	+$1M	﹤0.01%	1664
2021 Q1	$15.9M	Buy	+824,667	New	+$14.5M	﹤0.01%	1685

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Invesco's OCDX Position: Q2 2022 in Review

Invesco sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 148,009 shares — an estimated $2.76M sold.

Invesco first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $19M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Invesco reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Invesco sold 148,009 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.76M.
Invesco first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Invesco's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $19M in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.